Our monthly brief for decision-makers

Gain insights to operate in the international cannabis market

  • Learn about the impact of the latest laws and regulations.
 
  • Get insights on the likely evolution of regulatory reforms.
 
  • Monitor the political environment and cannabis policy papers & proposals.
 
  • Keep track of advocacy initiatives and lobbying efforts.
  • Track the latest market data: sales, imports, prescriptions, patients…
 
  • Stay up to date with M&A, supply deals, licensing & market entry.
 
  • Monitor the financial performance of the top companies in the market.
 
  • Follow new product and brand launches in international markets.

  • Track progress of clinical trials, scientific studies and R&D projects.
 
  • Follow the state of the art of cannabis science and technology.
 
  • Understand new product development trends.

Regulatory scrutiny fuels market instability — September 2025 Brief

September 2025 underscored the tension between rising demand and tightening compliance across global cannabis supply chains. Imports, prescriptions, and economic contributions continue to climb, yet regulatory reviews multiply — with stricter prescribing rules and compliance crackdowns reshaping access. Some countries move boldly toward reform, while others drift in regulatory grey zones — marking a sector entering a more disciplined, mature phase. Key...

Momentum Builds Unevenly in Global Cannabis Reform — July 2025 Brief

This month’s brief captures a pivotal moment in the global cannabis sector, as reform momentum continues but faces intensifying regulatory headwinds. Governments are tightening oversight on prescribing and distribution — with telemedicine under the spotlight in Germany and Australia — as markets adapt to shifting access models and research adds fresh weight to the public health debate. International trade flows...

From Bans to Breakthroughs: Markets Evolve Amid Legal and Market Shifts — June 2025 Brief

Hi , welcome to the Cannamonitor brief.This month, we track the global cannabis sector’s steady evolution, with regulators tightening control, businesses innovating amid rising demand, and new research underscoring cannabis’ potential role in public health. We highlight Germany’s regulatory clampdown on telemedicine and record medical imports, Poland’s rebound through hybrid clinics, and Australia’s prescription surge — alongside New Zealand’s landmark organic export...

Obtain Actionable Intelligence
into Global Cannabis Markets